dBaza Health
Stage
Seed | AliveTotal Raised
$50KLast Raised
$50K | 7 yrs agodBaza Health's Products & Differentiation
See dBaza Health's products and how their products differentiate from alternatives and competitors
MLT Platform
A customizable application that allows customers to quickly onboard and train their users. Using the data generated from user interactions within the platform, MLT will be able to identify gaps to comprehension and tailor content accordingly to ensure sustained engagement and drive patient adherence.
Differentiation
dbaza has streamlined a process that for our target customers, what once required months for strategy and development can now be achieved in the span of a few days.
Expert Collections containing dBaza Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
dBaza Health is included in 2 Expert Collections, including Digital Health.
Digital Health
12,922 items
Startups recreating how healthcare is delivered
Diabetes
1,750 items
Where is dBaza Health's headquarters?
dBaza Health's headquarters is located at 5001 Baum Blvd, Pittsburgh.
What is dBaza Health's latest funding round?
dBaza Health's latest funding round is Seed.
How much did dBaza Health raise?
dBaza Health raised a total of $50K.
Who are dBaza Health's competitors?
Competitors of dBaza Health include BrightInsight and 1 more.
What products does dBaza Health offer?
dBaza Health's products include MLT Platform.
Who are dBaza Health's customers?
Customers of dBaza Health include Insulet, Tandem Diabietes and Joslin Diabetes.
You May Also Like
Philips North America is a consumer electronics company that sells personal care, household, and other consumer electronics products. It is based in Cambridge, Massachusetts.
Trainual is a simple, intuitive and effective tool for small to medium-sized businesses to on-board or train employees, contractors, interns, volunteers and more.
Enterome aims to pioneer the development of disease management solutions based on a deep understanding of the gut microbiome. Understanding and modifying the changes that occur in the gut microbiome during disease and in response to therapeutic interventions represent an entirely new and untapped opportunity to impact medicine. Initially Enterome is using its expertise and proprietary technologies to develop novel diagnostic products to support patient stratification, personalized therapies and the clinical development of new drugs for the treatment of microbiome-related diseases such as inflammatory bowel diseases and metabolic diseases (diabetes and obesity). Enterome's Metagenotyping process has allowed it to develop biomarkers for treatment response prediction, disease activity monitoring and as potential companion diagnostics.
Health Vector accelerates digital health innovation through shortening software development life cycles.
DealCoachPro provides actionable coaching tips that guides the deal owner and team to focus on eliminating vulnerabilities and leveraging strengths to improve the likelihood to win more deals.
RealBio Technology is working on the commercialization of a cell and tissue culture technology for drug discovery and life science research. The RealBio D4 Culture System facilitates the growth of in vitro cultures that mimic the natural composition, configuration and function of normal and diseased tissue. The design ensures that cells can be cultured with an ideal mixture of gas and nutrients, delivered independently, to promote healthy, consistent growth, improving the culture quality. Results from testing indicate that our system outperforms other available 2D and 3D technologies.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.